Revolutionizing Facial Aesthetics: The Breakthrough of Fillderm® HA Filler with Lidocaine

Thanks to the latest publication in PRIME January/February 2024, a groundbreaking advancement has emerged in the realm of aesthetic medicine: the introduction of Fillderm® hyaluronic acid filler, now enhanced with lidocaine. In this blog post, we explore the pivotal findings from a multicentre clinical study headed by renowned specialists Drs. Jamel Fares, Jenny Simancas, Carlos Vivas, and Carlos Arguedas, emphasizing the product’s efficacy and safety in treating nasolabial folds and lip enhancement.

 

Wrinkles, the most apparent indicators of facial aging, are a result of various elements such as sun exposure, intrinsic aging, gravitational force, and loss of skin elasticity. Conventional approaches to these aging signs have often been inadequate.

The study spotlights Fillderm®, a novel dermal filler based on hyaluronic acid, designed to reinvigorate the face and maintain the ‘triangle of youth.’ It particularly targets the aging symptoms evident in the nasolabial folds and lips.

Conducted with 80 women, the study used the Global Aesthetic Improvement Scale and Wrinkle Severity Rating Scale for assessments. Post-treatment, remarkable improvements were noted in the nasolabial folds and lips, with lasting effects for six to eight months. Side effects were minor, mostly involving mild inflammatory reactions and ecchymoses.

Distinctive for its double-cross link technology, Fillderm® stands out with its high adaptability and seamless integration into tissue, ensuring no impact on facial movement or the natural aging process. Lidocaine’s addition significantly enhances the comfort level for patients during the procedure.

Demonstrated to be both effective and safe for facial aesthetic applications, particularly for augmenting the mid-face, Fillderm® marks a considerable contribution to the field of aesthetic medicine, offering a more comfortable and efficient option for facial rejuvenation.

This innovation marks a major leap forward in aesthetic medicine, opening new doors for individuals seeking facial rejuvenation. With Fillderm® at the forefront, we anticipate a future rich in more groundbreaking solutions in aesthetic treatments.

For more comprehensive insights and study details, visit:
https://www.prime-journal.com/prime-march-april-2024-issue/